Pitt-Hopkins-Like Syndrome 1
0.900
Biomarker
disease
CTD_human
Cortical dysplasia with focal epilepsy syndrome
0.810
Biomarker
disease
CTD_human
Pitt-Hopkins-Like Syndrome 1
0.900
Biomarker
disease
GENOMICS_ENGLAND
Possible case of Pitt-Hopkins syndrome in sibs.
11568923
2001
Pitt-Hopkins-Like Syndrome 1
0.900
GermlineCausalMutation
disease
ORPHANET
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
16571880
2006
Cortical dysplasia with focal epilepsy syndrome
0.810
GermlineCausalMutation
disease
ORPHANET
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
16571880
2006
Cortical dysplasia with focal epilepsy syndrome
0.810
Biomarker
disease
GENOMICS_ENGLAND
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.
16571880
2006
Autistic Disorder
0.500
Biomarker
disease
CTD_human
We identified a common polymorphism in contactin-associated protein-like 2 (CNTNAP2 ), a member of the neurexin superfamily, that is significantly associated with autism susceptibility.
18179894
2008
Autistic Disorder
0.500
Biomarker
disease
CTD_human
Identifying autism loci and genes by tracing recent shared ancestry.
18621663
2008
PITT-HOPKINS SYNDROME
0.340
Biomarker
disease
CTD_human
We now identified homozygous and compound-heterozygous deletions and mutations via molecular karyotyping and mutational screening in CNTNAP2 and NRXN1 in four patients with severe mental retardation (MR) and variable features, such as autistic behavior, epilepsy, and breathing anomalies, phenotypically overlapping with Pitt-Hopkins syndrome .
19896112
2009
Autistic Disorder
0.500
Biomarker
disease
CTD_human
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2 ), which were previously implicated in specific language disorder, autism and schizophrenia.
20157312
2011
Schizophrenia
0.400
Biomarker
disease
CTD_human
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2 ), which were previously implicated in specific language disorder, autism and schizophrenia .
20157312
2011
Language Development Disorders
0.310
Biomarker
group
CTD_human
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
20157312
2011
Speech Delay
0.310
Biomarker
disease
CTD_human
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
20157312
2011
Language Delay
0.300
Biomarker
phenotype
CTD_human
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
20157312
2011
Semantic-Pragmatic Disorder
0.300
Biomarker
phenotype
CTD_human
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
20157312
2011
Auditory Processing Disorder, Central
0.300
Biomarker
disease
CTD_human
Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
20157312
2011
Autism Spectrum Disorders
0.700
Biomarker
disease
CTD_human
Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2.
20176116
2010
Epilepsy
0.400
Biomarker
disease
CTD_human
Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies.
20502679
2010
Epilepsy, Cryptogenic
0.300
Biomarker
disease
CTD_human
Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies.
20502679
2010
×
CUI:
C0236018
Disease:
Aura
Aura
0.300
Biomarker
phenotype
CTD_human
Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies.
20502679
2010
Awakening Epilepsy
0.300
Biomarker
disease
CTD_human
Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies.
20502679
2010
Bipolar Disorder
0.310
Biomarker
disease
PSYGENET
The third interesting SNP rs802568 was at 7q35 within CNTNAP2 (p=8.92 × 10(-4), 1.38 × 10(-5), and 1.62 × 10(-7) for schizophrenia, bipolar disorder and meta-analysis, respectively).
20889312
2010
Autism Spectrum Disorders
0.700
Biomarker
disease
CTD_human
Comparison of the clinical and cytogenetic findings of our patients with previously reported patients, supports that haploinsuffiency of CNTNAP2 can result in language delay and/or autism spectrum disorder .
21082657
2010
Language Development Disorders
0.310
Biomarker
group
CTD_human
Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features.
21082657
2010
Speech Delay
0.310
Biomarker
disease
CTD_human
Deletion of 7q34-q36.2 in two siblings with mental retardation, language delay, primary amenorrhea, and dysmorphic features.
21082657
2010